Published in Euro Surveill on July 31, 2008
Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol (2009) 7.89
The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev (2010) 4.48
Multilocus sequence typing of Clostridium difficile. J Clin Microbiol (2009) 4.16
Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat Genet (2012) 4.10
Fecal microbiota transplantation and emerging applications. Nat Rev Gastroenterol Hepatol (2011) 2.47
Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon. Proc Natl Acad Sci U S A (2010) 2.11
Dentists, antibiotics and Clostridium difficile-associated disease. Br Dent J (2015) 2.10
Clostridium difficile associated infection, diarrhea and colitis. World J Gastroenterol (2009) 1.97
High-throughput DNA sequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria. Gut Microbes (2013) 1.85
Binary toxin and death after Clostridium difficile infection. Emerg Infect Dis (2011) 1.79
Comparison of strain typing results for Clostridium difficile isolates from North America. J Clin Microbiol (2011) 1.65
A mariner-based transposon system for in vivo random mutagenesis of Clostridium difficile. Appl Environ Microbiol (2009) 1.56
Lack of association between clinical outcome of Clostridium difficile infections, strain type, and virulence-associated phenotypes. J Clin Microbiol (2011) 1.37
Clostridium difficile carriage in elderly subjects and associated changes in the intestinal microbiota. J Clin Microbiol (2011) 1.34
Relapse versus reinfection: surveillance of Clostridium difficile infection. Clin Infect Dis (2011) 1.23
Clostridium difficile infection: new insights into management. Mayo Clin Proc (2012) 1.23
Coexistence of multiple multilocus variable-number tandem-repeat analysis subtypes of Clostridium difficile PCR ribotype 027 strains within fecal specimens. J Clin Microbiol (2010) 1.23
Multilocus variable-number tandem-repeat analysis and multilocus sequence typing reveal genetic relationships among Clostridium difficile isolates genotyped by restriction endonuclease analysis. J Clin Microbiol (2009) 1.21
Fidaxomicin inhibits spore production in Clostridium difficile. Clin Infect Dis (2012) 1.15
Evaluation of a chromogenic culture medium for isolation of Clostridium difficile within 24 hours. J Clin Microbiol (2010) 1.11
TcdC does not significantly repress toxin expression in Clostridium difficile 630ΔErm. PLoS One (2012) 1.02
Risk factors for Clostridium difficile toxin-positive diarrhea: a population-based prospective case-control study. Eur J Clin Microbiol Infect Dis (2012) 1.01
An enhanced DNA fingerprinting service to investigate potential Clostridium difficile infection case clusters sharing the same PCR ribotype. J Clin Microbiol (2011) 1.00
Clinically defined chemotherapy-associated bowel syndrome predicts severe complications and death in cancer patients. Haematologica (2011) 0.98
The A, B, BI, and Cs of Clostridium difficile. Clin Infect Dis (2009) 0.98
Clostridium difficile infections in China. J Biomed Res (2010) 0.97
Rapid diagnosis of Clostridium difficile infection by multiplex real-time PCR. Eur J Clin Microbiol Infect Dis (2011) 0.96
Mechanisms of hypervirulent Clostridium difficile ribotype 027 displacement of endemic strains: an epidemiological model. Sci Rep (2015) 0.96
Mechanisms behind variation in the Clostridium difficile 16S-23S rRNA intergenic spacer region. J Med Microbiol (2010) 0.94
Impact of ribotype 027 on Clostridium difficile infection in a geriatric department. Eur J Clin Microbiol Infect Dis (2013) 0.94
Epidemiology of Clostridium difficile infection and risk factors for unfavorable clinical outcomes: results of a hospital-based study in Barcelona, Spain. J Clin Microbiol (2013) 0.92
Clostridium difficile PCR Ribotype 018, a Successful Epidemic Genotype. J Clin Microbiol (2015) 0.91
Nontoxigenic Clostridium difficile protects hamsters against challenge with historic and epidemic strains of toxigenic BI/NAP1/027 C. difficile. Antimicrob Agents Chemother (2013) 0.91
Clostridium difficile: a new zoonotic agent? Wien Klin Wochenschr (2009) 0.89
Underestimation of Clostridium difficile infection among clinicians: an international survey. Eur J Clin Microbiol Infect Dis (2012) 0.88
Diverse temperate bacteriophage carriage in Clostridium difficile 027 strains. PLoS One (2012) 0.88
Antimicrobial Resistance and Reduced Susceptibility in Clostridium difficile: Potential Consequences for Induction, Treatment, and Recurrence of C. difficile Infection. Antibiotics (Basel) (2015) 0.86
Clostridium difficile-associated diarrhea in radiooncology: an underestimated problem for the feasibility of the radiooncological treatment? Radiat Oncol (2011) 0.85
Prevalence of Clostridium difficile in retail pork. Can Vet J (2010) 0.82
Clostridium difficile TcdC protein binds four-stranded G-quadruplex structures. Nucleic Acids Res (2013) 0.82
Outbreak of Clostridium difficile PCR ribotype 027--the recent experience of a regional hospital. BMC Infect Dis (2014) 0.82
Emergence of Clostridium difficile infection in tuberculosis patients due to a highly rifampicin-resistant PCR ribotype 046 clone in Poland. Eur J Clin Microbiol Infect Dis (2013) 0.81
Diagnosis of Clostridium difficile: real-time PCR detection of toxin genes in faecal samples is more sensitive compared to toxigenic culture. Eur J Clin Microbiol Infect Dis (2014) 0.81
Compared lethality rates of Clostridium difficile infections at the local, regional and national levels in France. New Microbes New Infect (2016) 0.78
Molecular characterization of nosocomial Clostridium difficile infection in pediatric ward in Iran. Springerplus (2015) 0.77
First Polish outbreak of Clostridium difficile ribotype 027 infections among dialysis patients. Eur J Clin Microbiol Infect Dis (2014) 0.77
The HtrA-like protease CD3284 modulates virulence of Clostridium difficile. Infect Immun (2014) 0.77
Clostridium difficile ribotypes in Austria: a multicenter, hospital-based survey. Wien Klin Wochenschr (2015) 0.76
Evaluation of a chromogenic culture medium for the detection of Clostridium difficile. Yonsei Med J (2014) 0.76
Clostridium difficile Infections amongst Patients with Haematological Malignancies: A Data Linkage Study. PLoS One (2016) 0.75
Surveillance of Clostridium difficile infections in a long-term care psychogeriatric facility: outbreak analysis and policy improvement. Arch Public Health (2015) 0.75
Fidaxomicin--the new drug for Clostridium difficile infection. Indian J Med Res (2015) 0.75
Longitudinal survey of Clostridium difficile presence and gut microbiota composition in a Belgian nursing home. BMC Microbiol (2016) 0.75
Interspecies Interactions between Clostridium difficile and Candida albicans. mSphere (2016) 0.75
A Decade of Development of Chromogenic Culture Media for Clinical Microbiology in an Era of Molecular Diagnostics. Clin Microbiol Rev (2017) 0.75
A Multi-Faceted Approach of One Teaching Hospital NHS Trust during the Clostridium difficile Epidemic-Antibiotic Management and Beyond. Antibiotics (Basel) (2016) 0.75
Emergence and spread of moxifloxacin-resistant Clostridium difficile ribotype 231 in Sweden between 2006 and 2015. New Microbes New Infect (2016) 0.75
Comparison of Multilocus Sequence Typing and the Xpert C. difficile/Epi Assay for Identification of Clostridium difficile 027/NAP1/BI. J Clin Microbiol (2015) 0.75
Nosocomial transmission of Clostridium difficile ribotype 027 in a Chinese hospital, 2012-2014, traced by whole genome sequencing. BMC Genomics (2016) 0.75
Poorer outcomes among cancer patients diagnosed with Clostridium difficile infections in United States community hospitals. BMC Infect Dis (2017) 0.75
Binary toxin and its clinical importance in Clostridium difficile infection, Belgium. Eur J Clin Microbiol Infect Dis (2016) 0.75
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect (2011) 17.47
Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med (1992) 8.15
Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA (2000) 7.21
Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect (2006) 6.90
A direct estimate of the human alphabeta T cell receptor diversity. Science (1999) 6.85
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol (1999) 5.58
Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science (1997) 5.55
Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat Med (1998) 5.08
The epic project: developing national evidence-based guidelines for preventing healthcare associated infections. Phase I: Guidelines for preventing hospital-acquired infections. Department of Health (England). J Hosp Infect (2001) 4.95
A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. J Clin Microbiol (1998) 4.79
Clonal lines of Salmonella enterica serotype Enteritidis documented by IS200-, ribo-, pulsed-field gel electrophoresis and RFLP typing. J Med Microbiol (1994) 4.43
Development of a new PCR-ribotyping method for Clostridium difficile based on ribosomal RNA gene sequencing. FEMS Microbiol Lett (1999) 4.27
Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc Natl Acad Sci U S A (1997) 4.03
Analysis of left ventricular wall movement during isovolumic relaxation and its relation to coronary artery disease. Br Heart J (1976) 3.79
Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination. Am J Med Genet (2001) 3.77
A study of infectious intestinal disease in England: microbiological findings in cases and controls. Commun Dis Public Health (1999) 3.72
An adjustable fetal weight standard. Ultrasound Obstet Gynecol (1995) 3.70
Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy. Rheumatology (Oxford) (2003) 3.70
T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today (1995) 3.60
The benefits and harms of breast cancer screening: an independent review. Br J Cancer (2013) 3.43
Protein products of the bithorax complex in Drosophila. Cell (1984) 3.40
Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease-helicase. Structure (1999) 3.37
Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates. Clin Microbiol Infect (2007) 3.27
Comparative phylogenomics of Clostridium difficile reveals clade specificity and microevolution of hypervirulent strains. J Bacteriol (2006) 3.05
A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group. N Engl J Med (1995) 3.04
The role of 'no-touch' automated room disinfection systems in infection prevention and control. J Hosp Infect (2012) 2.97
Use of sugammadex in a 'can't intubate, can't ventilate' situation. Br J Anaesth (2012) 2.91
Distinguishable epidemics of multidrug-resistant Salmonella Typhimurium DT104 in different hosts. Science (2013) 2.87
Search for a resonance decaying into WZ boson pairs in pp collisions. Phys Rev Lett (2010) 2.83
Outbreak of isoniazid resistant tuberculosis in north London. Thorax (2004) 2.82
Comparison of PCR-ribotyping, arbitrarily primed PCR, and pulsed-field gel electrophoresis for typing Clostridium difficile. J Clin Microbiol (2000) 2.79
Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis (1994) 2.67
Relationship of urethral retro-resistance pressure to urodynamic measurements and incontinence severity. Neurourol Urodyn (2004) 2.64
Estimating the date of confinement: ultrasonographic biometry versus certain menstrual dates. Am J Obstet Gynecol (1996) 2.64
Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013. Euro Surveill (2013) 2.63
Host adapted serotypes of Salmonella enterica. Epidemiol Infect (2000) 2.58
Association of heterogeneous nuclear ribonucleoprotein A1 and C proteins with reiterated AUUUA sequences. J Biol Chem (1993) 2.57
Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J Infect Dis (1990) 2.52
Pandemic Influenza A (H1N1) 2009 and mortality in the United Kingdom: risk factors for death, April 2009 to March 2010. Euro Surveill (2010) 2.49
Distribution of Ultrabithorax proteins in Drosophila. EMBO J (1985) 2.49
Comparison of serogrouping and polyacrylamide gel electrophoresis for typing Clostridium difficile. J Clin Microbiol (1986) 2.43
Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain. Antimicrob Agents Chemother (2001) 2.42
Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infection. Proc Natl Acad Sci U S A (1998) 2.39
Simple treatment for torus fractures of the distal radius. J Bone Joint Surg Br (2001) 2.39
Transient intestinal carriage after ingestion of antibiotic-resistant Enterococcus faecium from chicken and pork. N Engl J Med (2001) 2.38
Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect (2011) 2.38
Four country healthcare associated infection prevalence survey 2006: overview of the results. J Hosp Infect (2008) 2.35
Transfer RNA as a cofactor coupling amino acid synthesis with that of protein. Proc Natl Acad Sci U S A (1968) 2.31
Echocardiographic assessment of abnormal left ventricular relaxation in man. Br Heart J (1976) 2.30
The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. Euro Surveill (2012) 2.29
Pertussis disease burden in the household: how to protect young infants. Clin Infect Dis (2010) 2.26
Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev (2005) 2.25
Omeprazole, campylobacter pylori, and duodenal ulcer. Lancet (1989) 2.24
Viral gastroenteritis increases the reports of Clostridium difficile infection. J Hosp Infect (2007) 2.23
Estimation of lung volumes from chest radiographs using shape information. Thorax (1979) 2.23
Oligoclonality of tumor-infiltrating lymphocytes from human melanomas. J Immunol (1994) 2.21
Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation. Gynecol Oncol (2001) 2.20
No time for handwashing!? Handwashing versus alcoholic rub: can we afford 100% compliance? Infect Control Hosp Epidemiol (1997) 2.19
Seasonal variations in serum 25-hydroxycholecalciferol in healthy people. Lancet (1974) 2.19
The function of PS integrins during Drosophila embryogenesis. Cell (1989) 2.19
Experimental aminoglycoside nephrotoxicity. J Lab Clin Med (1975) 2.19
The Drosophila PS2 antigen is an invertebrate integrin that, like the fibronectin receptor, becomes localized to muscle attachments. Cell (1987) 2.18
Left ventricular filling in hypertrophic cardiomyopathy. An angiographic study. Br Heart J (1977) 2.18
Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing. J Clin Microbiol (2005) 2.18
Characterization of Clostridium difficile isolates using capillary gel electrophoresis-based PCR ribotyping. J Med Microbiol (2008) 2.17
Contamination of healthcare workers' hands with Clostridium difficile spores after caring for patients with C. difficile infection. Infect Control Hosp Epidemiol (2013) 2.17
The stimulation of pp60v-src kinase activity by vanadate in intact cells accompanies a new phosphorylation state of the enzyme. J Biol Chem (1984) 2.15
Comparative study of mupirocin and oral co-trimoxazole plus topical fusidic acid in eradication of nasal carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1995) 2.14
Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin Microbiol Infect (2009) 2.13
[Increasing incidence of scabies in France, 1999-2010, and public health implications]. Ann Dermatol Venereol (2012) 2.11
New Delhi metallo-beta-lactamase 1-producing Enterobacteriaceae: emergence and response in Europe. Euro Surveill (2010) 2.09
CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. Immunity (1996) 2.09
Fibrinogen function is impaired in whole blood from patients with cyanotic congenital heart disease. Int J Cardiol (2012) 2.08
Immunochemical fingerprinting of Clostridium difficile strains isolated from an outbreak of antibiotic-associated colitis and diarrhoea. J Med Microbiol (1984) 2.07
Comparison of toxinotyping and PCR ribotyping of Clostridium difficile strains and description of novel toxinotypes. Microbiology (2001) 2.04
Echocardiographic features of secondary left ventricular hypertrophy. Br Heart J (1979) 2.04
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals. Antimicrob Agents Chemother (2007) 2.04
Thoracic anaesthesia. Br J Theatre Nurs (1996) 2.03
[Antimicrobial therapy in exacerbated chronic obstructive pulmonary disease]. Arch Bronconeumol (2002) 2.03
Infection control measures to limit the spread of Clostridium difficile. Clin Microbiol Infect (2008) 2.01
Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin. Antimicrob Agents Chemother (2002) 2.00
Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. A comparative study. Medicine (Baltimore) (2001) 2.00
Visceral leishmaniasis in immunocompromised hosts. Am J Med (1987) 1.99
Serotyping of Clostridium difficile. J Clin Microbiol (1988) 1.98
Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands. Clin Infect Dis (2007) 1.97
A STUDY OF RICKETTSIAE GROWN ON AGAR TISSUE CULTURES. J Exp Med (1939) 1.96
The RNA code and protein synthesis. Cold Spring Harb Symp Quant Biol (1966) 1.96